chr2:111883195:> Detail (hg19) (BCL2L11)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr2:111,883,195-111,886,097 |
| hg38 | chr2:111,125,618-111,128,520 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| chronic myeloid leukemia | Imatinib | B |
Predictive
|
Supports
|
Resistance | Common Germline | 4 | 22426421 | Detail |
| lung non-small cell carcinoma | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor | B |
Predictive
|
Supports
|
Resistance | Common Germline | 4 | 22426421 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| DNA sequencing was performed in five Ph+ CML samples with sensitivity or resistance to imatinib. A s... | CIViC Evidence | Detail |
| The BIM (BCL2L11) deletion polymorphism was identified in an EGFR Mutant NSCLC cell line with resist... | CIViC Evidence | Detail |
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr2:111,883,195-111,886,097
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- DELETION POLYMORPHISM
- Transcript 1 (CIViC Variant)
- ENST00000393256.3
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/526
Genome browser